Education&ScienceAPSR ESAP

ESAP Japan 2013

Interstitial Lung Disease: Progress in Diagnosis and Management of Idiopathic Interstitial Pneumonias

11 November 2013 Yokohama

This pre-congress ESAP took place at Pacifico Yokohama, Japan, prior to the 18th Congress of the APSR.

Junior and senior training medical doctors, registered nurses, advanced practice registered nurses, paramedical and care givers, who are interested in learning the current management and treatment of idiopathic pulmonary fibrosis, idiopathic interstitial pneumonias and about the new concept of categorization based on ethnic differences in clinical behavior.

At the conclusion of this session, the participants were able to:

  • Understand the pathophysiology of idiopathic interstitial pneumonias
  • Describe the new concept of categorization of idiopathic interstitial pneumonias
  • Recognize the common features, differences and characteristics of interstitial pneumonias

The educational seminar provided useful information and interpretations of the evidence-based guideline of idiopathic interstitial pneumonias that was recently updated. In particular, the audience was educated on the innovative view and challenges of trying to manage patients with idiopathic pulmonary fibrosis (IPF) in the real-world clinical practice. Two Japanese speakers talked about ethnic differences between asian and caucasian patients with IPF, focusing on the clinical management and diagnosis of acute exacerbations of the disease. In addition, the seminar provided recent concepts and future aspects of clinical trials that are globally being undertaken in patients with IPF.

Chairs:

Arata Azuma (Nippon Medical School, Japan)
Sakae Homma (Toho University Omori Medical Center, Japan)

Speakers:

Kevin K Brown (National Jewish Health, USA)

Luca Richeldi (University of Southampton, UK)
Ulrich Costabel (University of Duisburg-Essen, Germany)
Hiroyuki Taniguchi (Tosei General Hospital, Japan)
Yoshikazu Inoue (National Hospital Organization Kinki-Chuo Chest Medical Center, Japan)

Opening Address by Chairs

Lectures:

  1. Idiopathic Interstitial Pneumonias (IIP): classification and disease behavior
    Kevin K Brown
  2. New IPF guideline and its future update
    Luca Richeldi
  3. Essential rules and requirements for rare lung disease global clinical trial: Researcher’s experience from Pirfenidone development
    Ulrich Costabel
  4. Diagnosis and treatment of acute exacerbation of idiopathic pulmonary fibrosis
    Hiroyuki Taniguchi
  5. Global understandings and disagreements of the concepts and managements of IIPs
    Yoshikazu Inoue

Closing Remarks by Chairs

Participants were from:
Australia 1
Bangladesh 1
Hong Kong 13
China 1
India 1
Indonesia 2
Japan 31
Philippines 1
Republic of Korea 4
Singapore 2
UAE 1
Vietnam 1
Total 59